| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 86.76B | 91.03B | 141.00B | 132.02B | 167.95B | 176.24B |
| Gross Profit | 21.54B | 19.76B | 23.25B | 28.12B | 49.77B | 51.40B |
| EBITDA | 13.27B | 19.30B | 21.97B | 26.76B | 50.07B | 52.59B |
| Net Income | 8.74B | 7.70B | 10.43B | 15.66B | 33.27B | 35.16B |
Balance Sheet | ||||||
| Total Assets | 253.14B | 254.64B | 246.19B | 243.98B | 230.51B | 200.97B |
| Cash, Cash Equivalents and Short-Term Investments | 63.84B | 70.74B | 70.57B | 68.62B | 93.81B | 89.06B |
| Total Debt | 26.49B | 27.58B | 20.29B | 22.14B | 11.90B | 10.48B |
| Total Liabilities | 51.94B | 54.26B | 48.22B | 47.98B | 38.69B | 32.76B |
| Stockholders Equity | 189.09B | 187.94B | 185.32B | 183.64B | 183.69B | 161.82B |
Cash Flow | ||||||
| Free Cash Flow | 6.75B | 7.16B | 5.91B | -17.00B | 18.70B | 24.83B |
| Operating Cash Flow | 8.29B | 18.48B | 20.07B | 9.65B | 33.90B | 34.80B |
| Investing Cash Flow | -18.27B | -13.33B | -19.31B | -5.28B | -21.67B | -26.77B |
| Financing Cash Flow | -1.89B | -385.48M | -4.41B | -5.72B | -11.60B | -13.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $18.83B | 13.40 | 7.10% | 0.74% | -6.34% | 210.97% | |
77 Outperform | $7.08B | 17.39 | 30.10% | 0.47% | 1.50% | -4.44% | |
77 Outperform | $39.52B | 37.04 | 13.56% | 0.67% | 6.54% | 32.48% | |
76 Outperform | £87.92B | 26.14 | 15.21% | 1.17% | 4.28% | 0.39% | |
73 Outperform | $38.48B | 35.12 | 11.63% | 0.51% | 1.99% | -41.08% | |
66 Neutral | $16.75B | 12.05 | 4.94% | 4.13% | -28.23% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |